Further prospective studies of cardiac disturbances in ATP1A3-related conditions to test the utility and cost-effectiveness of this approach and to identify potential precipitating factors for life-threatening cardiac arrhythmias are warranted. This evidence concerns the gene ATP1A3 and chronic obstructive pulmonary disease.